AzTrials
AzTrials

Voice DisordersBRAVO1NCT06126627

Brain and Voice Signatures in Teachers

A study testing Stress induction in people with Voice Disorders and Voice Fatigue, run by University Hospital, Bonn at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Primary muscle tension dysphonia voice disorder with symptoms of vocal strain and vocal fatigue is common and can have a significant negative impact on quality of Life. Yet, primary muscle tension dysphonia's causes are unknown precluding precise diagnostic classification. Read more about this study

Who is it for?
Ages 21 to 39 years, women onlyHealthy volunteers can take part
Conditions the study is for
Voice Disorders, Voice Fatigue
What is being tested?
Stress induction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteGermany
Study dates
1 Aug 2023to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 39 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Teachers (max. 10 years full-time) or student teachers in good health between 21 and 39 years with symptoms of vocal fatigue.
  • Control participants in good health between 21 and 39 years without symptoms of vocal fatigue.

Who cannot join

  • Lefthandedness
  • Smoking (past 5 years)
  • Known changes of the vocal folds (e.g., vocal fold nodules), vocal fold paralysis, surgeries on the larynx or thryoid or current organic or neurological changes of the vocal folds or vocal function per videoendoscopy and -stroboscopy of the larynx
  • History of voice therapy
  • Hoarseness
  • Respiratory illness, allergies (respiratory, silver), reflux or asthma at time of participation
Show all 14Show fewer
  • Hearing disorder or hearing aids
  • Psychological, neurological or endocrinological disorders
  • Psychotropic or steorid medications
  • Body mass index > 30
  • Indications against MRI such as metail parts in or on the body (e.g., permanent dental prostheses or braces, screws, prostheses, piercings or large tattoos
  • Nearsightedness > -5 diopters, if only glasses are worn
  • Claustrophobia
  • Pregnancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germany1 site, 1 recruiting
  • University Hospital Bonn

    Bonn, 53127

    Maria Dietrich, PhD, +49228287 ext. 11107, Maria.Dietrich@ukbonn.de

    Recruiting

Other trials in Germany

About this study

Official title: Neurobiological and Psychobiological Signatures of Vocal Effort in Early Career Teachers

Primary muscle tension dysphonia voice disorder with symptoms of vocal strain and vocal fatigue is common and can have a significant negative impact on quality of Life. Yet, primary muscle tension dysphonia's causes are unknown precluding precise diagnostic classification. Stress and personality are thought to play a role and thus, the project aims to determine the practical and clinical effect of stress on the control of voice and speech in the brain. Participants are female early career teachers and student teachers with symptoms of vocal fatigue, as well as control participants without vocal fatigue, who perform speech tasks on two different occasions. Neural (imaging of brain), psychobiological (saliva, personality), and voice and speech (muscle activity of voice muscles on the neck with surface sensors, audio recordings) data will compare reactivity patterns of teachers who are stressresponders with those who are nonresponders as well as control participants. The central hypothesis is that voice box stress responders have heightened emotion-motor activations involving the emotional voice production pathway, which correlate with changes in voice muscle activity in the anterior neck. The results will provide fundamentally missing data in our understanding of the role of stress in vocal complaints and will yield new insights about the neural underpinnings of primary muscle tension dysphonia. The study findings will have a significant impact on how clinicians identify so-called laryngoresponders to help them prevent voice disorders.

Being tested
Stress induction
Keywords
voice disorders, vocal fatigue, occupational voice disorders, stress reactivity, vocal control, laryngeal motor cortex, teachers, speech motor control, voice motor control
Medical subject headings
Voice Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stress inductionBehavioural

    Induction of anticipatory stress to compare voice and speech control and production with and without exposure to stress.

Study groups in NCT06126627
Study groupRoleWhat they receive
Teachers/student teachers with vocal fatigueExperimentalTeachers/student teachers with vocal fatigue based on Vocal Fatigue Index (VFI, German). Pre-Screening and Screening. Experiment 1: MRI with MRI-compatible surface electrodes on the neck and audio recordings during MRI with and without stress induction. Prior to MRI, questionnaires on voice, personality, and stress and practice oft the tasks. During experiment, collection of saliva samples (before, during, and after MRI). During MRI, multiple subjective ratings of emotional state by the participants. Experiment 2 (approximately 2 weeks later): Speech tasks with surface electromyographic sensors applied to the neck with concurrent audio recordings. Prior to the experiment questionnaires on voice and practice of tasks. Subjective ratings of vocal and cognitive effort during the experiment by the participants.
Receives: Behavioral: Stress induction
Control groupActive comparatorControl participants without vocal fatigue based on Vocal Fatigue Index (VFI, German). Same experimental procedures as in arm 1.
Receives: Behavioral: Stress induction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vocal fatigue

    Raw scores, Vocal Fatigue Index, VFI Factor 1

    Measured: through study completion, an average of 1 month

  2. BOLD MRI area 4p

    MRI activation in regions of interest (BOLD area 4p in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  3. Salivary cortisol

    Salivary cortisol (nmol/L) to determine stressresponders and nonresponders

    Measured: through study completion, an average of 1 month

  4. Suprahyoid muscle activity

    Suprahyoid muscle activity (RMS)

    Measured: through study completion, an average of 1 month

  5. Infrahyoid muscle activity

    Infrahyoid muscle activity (RMS)

    Measured: through study completion, an average of 1 month

  6. Personality, Social Potency

    Personality trait Social Potency (T-scores, Multidimensional Personality Questionnaire, MPQ)

    Measured: through study completion, an average of 1 month

  7. Personality, Stress Reaction

    Personality trait Stress Reaction (T-scores, Multidimensional Personality Questionnaire, MPQ)

    Measured: through study completion, an average of 1 month

  8. Personality, social anxiety

    Personality trait social anxiety (T-scores, Liebowitz Social Anxiety Scale, LSAS-fear)

    Measured: through study completion, an average of 1 month

Secondary outcomes (21)
  1. Vocal fatigue

    Raw scores, Vocal Fatigue Index, VFI Factor 2 and 3

    Measured: through study completion, an average of 1 month

  2. Voice quality of life

    Raw data, Voice Handicap Index, VHI

    Measured: through study completion, an average of 1 month

  3. Vocal tract discomfort

    Raw data, Vocal Tract Discomfort Scale, VTD

    Measured: through study completion, an average of 1 month

  4. Informal questionnaire on vocal health

    Raw data informal questionnaire on vocal health

    Measured: through study completion, an average of 1 month

  5. BOLD MRI SMA

    MRI activation in regions of interest (BOLD area SMA in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  6. BOLD MRI ACC

    MRI activation in regions of interest (BOLD area ACC in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  7. BOLD MRI MCC

    MRI activation in regions of interest (BOLD area MCC in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  8. BOLD MRI Amygdala

    MRI activation in regions of interest (BOLD area Amygdala in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  9. BOLD MRI PAG

    MRI activation in regions of interest (BOLD area PAG in mean %) as a function of speech tasks with and without stress induction

    Measured: through study completion, an average of 1 month

  10. Personality, Wellbeing

    Personality trait Wellbeing (T-scores, Multidimensional Personality Questionnaire, MPQ)

    Measured: through study completion, an average of 1 month

  11. Personality, Social Closeness

    Personality trait Social Closeness (T-scores, Multidimensional Personality Questionnaire, MPQ)

    Measured: through study completion, an average of 1 month

  12. Personality, social anxiety

    Personality trait social anxiety (T-scores, Liebowitz Social Anxiety Scale, LSAS-total)

    Measured: through study completion, an average of 1 month

  13. Personality, self-esteem

    Personality self-esteem (raw data, Rosenberg self-esteem scale)

    Measured: through study completion, an average of 1 month

  14. Behavioral inhibition and exhibition

    Behavioral inhibition and exhibition (raw data, BIS/BAS scales, BIS subscale)

    Measured: through study completion, an average of 1 month

  15. Chronic Stress

    Chronic stress (T-scores, Trier Inventory of Chronic Stress, TICS)

    Measured: through study completion, an average of 1 month

  16. Handedness

    Handedness (raw data, Edinburgh Handedness Inventory, EHI)

    Measured: through study completion, an average of 1 month

  17. State positive and negative affect

    State positive and negative affect (raw data, Positive and Negative Affect Schedule, PANAS)

    Measured: through study completion, an average of 1 month

  18. Voice quality, relative fundamental frequency

    Voice quality, relative fundamental frequency (relative fundamental frequency, RFF in semitones [ST])

    Measured: through study completion, an average of 1 month

  19. Voice quality, cepstral-spectral analysis

    Voice quality, cepstral-spectral analysis (cepstral peak prominence in dB)

    Measured: through study completion, an average of 1 month

  20. Perceived vocal effort

    Perceived vocal effort (raw data, BORG-CR-10)

    Measured: through study completion, an average of 1 month

  21. Cognitive effort

    Cognitive effort (raw data, NASA-TLX)

    Measured: through study completion, an average of 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2023
  2. Study start1 Aug 2023
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06126627
Sponsor's protocol ID
R01DC018026
Acronym
BRAVO1
Status last verified
Aug 2025
First submitted
19 Oct 2023
Last updated
27 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The raw data, on which the conclusions are based, will be shared by the authors without any inadmissible caveats starting 6 months post publication with any qualified researcher upon request.

Questions about this trial

What is this clinical trial studying?

A study testing Stress induction in people with Voice Disorders and Voice Fatigue, run by University Hospital, Bonn at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maria Dietrich, PhD (+49228287 ext. 11107, Maria.Dietrich@ukbonn.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vocal fatigue (time frame: through study completion, an average of 1 month). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in